ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models-Reference-Cited by-同舟云学术

ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models

Published:2016-07-14 Issue: Volume: Page:now147
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:Neuro Oncol

Author:

Ziegler Jadith,Pody Richard,Coutinho de Souza Patricia,Evans Blake,Saunders Debra,Smith Nataliya,Mallory Samantha,Njoku Charity,Dong Yunzhou,Chen Hong,Dong Jiali,Lerner Megan,Mian Osamah,Tummala Sai,Battiste James,Fung Kar-Ming,Wren Jonathan D.,Towner Rheal A.

Funder

Oklahoma Medical Research Foundation

the Chapman Foundation

National Institute of General Medical Sciences of the National Institutes of Health (NIH NIGMS)

NIH NIGMS

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/19/2/175/17681960/now147.pdf

Reference43 articles.

1. American Cancer Society: Cancer Facts and Figures 2014. Available at http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf . Atlanta, GA: American Cancer Society; 2014. Last accessed March 26, 2014.

2. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011

3. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009

4. Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology

5. Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tanshinone IIA normalized hepatocellular carcinoma vessels and enhanced PD-1 inhibitor efficacy by inhibiting ELTD1;Phytomedicine;2024-01

2. Advances in antibody-based drugs and their delivery through the blood-brain barrier for targeted therapy and immunotherapy of gliomas;International Immunopharmacology;2023-04

3. 5-Hydroxymethylcytosines in circulating cell-free DNA reveal a diagnostic biomarker for glioma;Heliyon;2022-10

4. A tale of two multi‐focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone‐based OKN‐007;Journal of Cellular and Molecular Medicine;2021-12-14

5. ELTD1 Activation Induces an Endothelial-EMT Transition to a Myofibroblast Phenotype;International Journal of Molecular Sciences;2021-10-19